Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons
Fertile Battle
Published
VOLUME 114, ISSUE 4, P725-738
Authors:
Marie-Madeleine Dolmans, M.D., Ph.D., Hugh S. Taylor, M.D., Kenny A. Rodriguez-Wallberg, M.D., Ph.D., Zeev Blumenfeld, M.D., Matteo Lambertini, M.D., Ph.D., Michael von Wolff, M.D., Jacques Donnez, M.D., Ph.D.
Abstract:
Con: GnRH-a should not be used for fertility preservation in women receiving chemotherapy
Pro: PRO: GnRH-a should be used for fertility preservation in women receiving chemotherapy
Created with Survey maker
